Diabetic Cardiomyopathy
📧 Sign up to get email alerts when something new happens for Diabetic Cardiomyopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: IMPROVE-DiCE: Study to Evaluate Effect of IMB-1018972 on Cardiac Energetics in T2DM & Obesity (Pt 1) With HFpEF (Pt 2) [Phase 2]
This update reports the completion of a Phase 2 study evaluating IMB-1018972 for improving cardiac energetics in adults with type 2 diabetes…
-
CLINICAL_TRIALS trial_result · 2022-12-08Clinical Trial Update: Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy [Phase 3]
Phase 3 trial update on AT-001 for diabetic cardiomyopathy reports safety and efficacy data.
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Efficacy of Trimetazidine in Diabetic Patients [Phase 2]
Phase 2 trial update evaluating the efficacy of trimetazidine in type 2 diabetes and diabetic cardiomyopathy.
-
CLINICAL_TRIALS trial_result · 2019-07-10Clinical Trial Update: REmodelling in Diabetic CardiOmapathy: Gender Response to PDE5i InhibiTOrs [Phase 4]
Phase 4 trial update investigating gender response to PDE5 inhibitors in diabetic cardiomyopathy and type 2 diabetes patients; study complet…
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: Impact of Pharmacist in Cardiology Service [NA]
This completed clinical trial evaluates the impact of a pharmacist in the cardiology service on care delivery for patients with diabetic car…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Mechanisms Responsible for Cardiac and Skeletal Muscle Energetic Impairment in Diabetes [Phase 1, Phase 2]
A Phase 1/2 clinical trial examining mechanisms underlying energetic impairment in cardiac and skeletal muscle in diabetes, focusing on diab…